Literature DB >> 3539209

Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome.

J E Mitchell, D E Laine, J E Morley, A S Levine.   

Abstract

We undertook a study to see if putative anorectic agents could attenuate binge eating episodes in bulimic patients. Bolus intravenous administration, followed by continuous intravenous infusion of naloxone, resulted in a significant decrease in the amount of food consumed during binge-eating episodes, whereas bolus followed by continuous intravenous infusion of CCK-8 failed to significantly suppress binge eating behavior. These results suggest that the endogenous opioid system is involved in the maintenance of binge eating behavior in patients with bulimia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3539209     DOI: 10.1016/0006-3223(86)90331-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

Review 1.  Endorphins: the basis of pleasure?

Authors:  C H Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

2.  Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.

Authors:  Samuel R Chamberlain; Karin Mogg; Brendan P Bradley; Annelize Koch; Chris M Dodds; Wenli X Tao; Kay Maltby; Bhopinder Sarai; Antonella Napolitano; Duncan B Richards; Edward T Bullmore; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2012-07-03       Impact factor: 4.530

Review 3.  Appetite regulation: the role of peptides and hormones.

Authors:  J E Morley
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

Review 4.  Anorexia nervosa and bulimia nervosa.

Authors:  D S Goldbloom; S H Kennedy; A S Kaplan; D B Woodside
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

Review 5.  Feeding, drug abuse, and the sensitization of reward by metabolic need.

Authors:  K D Carr
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

6.  Naltrexone in primary hyperphagic obesity wity hypochondriacal disorder - a clinical study.

Authors:  R S Pandey; S C Arya; D K Subbakrishna
Journal:  Indian J Psychiatry       Date:  1999-04       Impact factor: 1.759

7.  A role for clinical psychology in health care and policy concerning the physical environment.

Authors:  M B Jasnoski Gregerson
Journal:  J Clin Psychol Med Settings       Date:  1995-06

Review 8.  Rational therapy of eating disorders.

Authors:  S J Crow; J E Mitchell
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 9.  Gastrointestinal peptides in eating-related disorders.

Authors:  Kimberly R Smith; Timothy H Moran
Journal:  Physiol Behav       Date:  2021-05-11

10.  Sweet/Fat Preference Taste in Subjects Who are Lean, Obese and Very Obese.

Authors:  Jennifer Leohr; Maria C Kjellsson
Journal:  Pharm Res       Date:  2020-11-19       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.